Ganirelix Acetate Injection, Solution
Product Images NDC 83301-0082

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ganirelix Acetate (NDC 83301-0082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ganirelix 01)

Chemical structure diagram showing the molecular formula of Ganirelix Acetate. The diagram details the sequence of amino acid residues in the peptide, including side chains and functional groups, along with acetate and water components indicated in the formula.*

FDA Label Image

Principal Display Panel (250 mcg/0.5 mL Syringe Carton)

Ganirelix Acetate Injection 250 mcg/0.5 mL subcutaneous solution in a single-dose sterile prefilled syringe. The label includes dosage information, storage instructions, and notes that packaging components are free from dry natural rubber/latex. The product is labeled as prescription only, manufactured for Mullan Pharmaceutical Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.